Related Experiment Videos

Identification of a point mutation in the folate receptor gene that confers a dominant negative phenotype

R B Orr1, B A Kamen

  • 1Department of Pediatrics and Pharmacology, University of Texas Southwestern Medical Center at Dallas 75235-9063.

Cancer Research
|February 15, 1995
PubMed

Insights

Mutant folate receptors in head and neck cancer cells are nonfunctional and can block normal folate receptor alpha function. This dominant negative effect impacts folate binding and cellular localization.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Head and neck squamous cell carcinoma (HNSCC) cells, like UM-SCC-38, exhibit limited folate receptor alpha (FRα) expression.
  • This limited FRα expression is insufficient for binding folic acid or 5-methyltetrahydrofolic acid.

Purpose of the Study:

  • To investigate the functional consequences of identified mutations in the folate receptor alpha open reading frame.
  • To determine if mutant folate receptor proteins can interfere with normal folate receptor function.

Main Methods:

  • Analysis of three distinct folate receptor alpha mutations within the open reading frame.
  • Functional assays to assess folate binding capabilities of mutant proteins.
  • Transfection of MA104 cells (a receptor-positive cell line) with mutant folate receptor genes.
  • Immunofluorescence microscopy to visualize protein expression and localization.

Main Results:

  • The three identified folate receptor alpha mutants are nonfunctional, failing to bind folate.
  • Expression of the FR-67 mutant in MA104 cells leads to a dominant negative phenotype, characterized by reduced folate binding and increased membrane antigen levels.
  • Coexpression of FR-67 with normal folate receptor alpha in MA104 cells induces the formation of intracellular protein clusters near the nucleus.

Conclusions:

  • This study presents the first evidence of a mutant folate receptor alpha protein exhibiting a dominant negative effect on normal receptor function.
  • The FR-67 mutant can disrupt normal folate receptor alpha activity and cellular localization.
  • Understanding these mutant receptor behaviors is crucial for potential therapeutic strategies in HNSCC.

Related Concept Videos